CK-MB Activity Unit Converter
CK-MB Activity Unit Converter
Convert CK-MB catalytic activity between U/L and µkat/L. First, the thing that goes wrong most often: CK-MB activity and CK-MB mass are different measurements, and a result in U/L cannot be read against a threshold in ng/mL.
CK-MB Activity converter
Activity unitsCK-MB activity 36 U/L
The activity ladder
1 U/L = 1/60 µkat/L = 0.0166667 µkat/L = 16.6667 nkat/L
U/L and IU/L are the same number
- why the factor is 1/60
- the unit is per minute and the katal is per second, so the only arithmetic in the conversion is 60 seconds in a minute. Nothing about CK-MB itself enters into it
- no molar conversion
- this is a catalytic activity, not a concentration of protein. There is no molecular weight to divide by and no nmol/L equivalent — an activity in U/L measures what the enzyme does, not how much of it is there
- activity is not mass
- CK-MB mass assays report ng/mL or µg/L of CK-MB protein against an immunoassay calibrator. The two scales are unrelated, they respond differently to inactive enzyme, and no factor converts between them
- the internal check
- a published adult interval of under 24 U/L and under 0.4 µkat/L is the same statement twice: 24 × 0.0166667 = 0.400. If a report's two figures do not agree that way, one of them is wrong
Worked example
CK-MB activity 36 U/L
36 ÷ 60 = 0.600 µkat/L = 600 nkat/L = 36 IU/L
Above the indicative adult limit of 24 U/L (0.4 µkat/L)
Before treating that as cardiac: adenylate kinase from haemolysis and macro-CK both raise this measurement without any myocardial injury, and skeletal muscle injury raises it genuinely
This number cannot be compared with a CK-MB mass result in ng/mL, and it cannot be used in the CK-MB relative index, whose published cut-offs are defined for the mass assay
Two different tests with the same name
| CK-MB activity | CK-MB mass | |
|---|---|---|
| What is measured | How fast the enzyme works | How much CK-MB protein is present |
| Units | U/L, IU/L, µkat/L, nkat/L | ng/mL, µg/L |
| Usual method | Immunoinhibition — anti-CK-M antiserum blocks the M subunits | Two-site immunoassay against a protein calibrator |
| Limit of detection | Poor; the method has low analytical sensitivity | Typically below 1 µg/L |
| False positives | Adenylate kinase from red cells, macro-CK, CK-BB | Fewer, but macro-CK still interferes with some methods |
| Used in the relative index? | No — the published cut-offs are for the mass assay | Yes |
| Still in routine use? | Largely abandoned | Superseded by troponin, but still reported in some laboratories |
Converting the activity ladder
| From | To | Multiply by | 36 U/L is |
|---|---|---|---|
| U/L | µkat/L | 0.0166667 (÷ 60) | 0.600 µkat/L |
| U/L | nkat/L | 16.6667 | 600 nkat/L |
| U/L | IU/L | 1 | 36 IU/L |
| µkat/L | U/L | 60 | — |
| U/L | ng/mL | no conversion exists | — |
Why almost nobody measures this any more
Creatine kinase MB can be measured two entirely different ways, and the results are not interchangeable. An activity assay measures how fast the enzyme converts its substrate, and reports units per litre — a unit being one micromole of substrate per minute, which is why the SI conversion to microkatals per litre is nothing more than dividing by sixty. A mass assay measures how much CK-MB protein is present, using a two-site immunoassay against a protein calibrator, and reports nanograms per millilitre. No factor converts between the two scales, and a mass-derived threshold applied to an activity result, or the reverse, is meaningless.
The usual activity method is immunoinhibition. An antiserum against the CK-M subunit blocks the two M subunits of CK-MM and the single M subunit of CK-MB; whatever B-type activity remains is measured and doubled to estimate CK-MB. The weakness is built into the design: anything else in the sample that survives the inhibition step and contributes to the measured reaction is counted as CK-MB. Adenylate kinase, released from red cells whenever a sample is haemolysed, inflates the measured creatine kinase activity. Macro-CK — a benign complex of CK with an immunoglobulin, commonest in older people — is read as CK-MB, and can produce the impossible result of a CK-MB higher than the total CK. CK-BB from brain, bowel or tumour does the same.
Those false positives, together with poor analytical sensitivity, are why laboratories moved to mass assays and then largely stopped measuring CK-MB at all. High-sensitivity cardiac troponin is more cardiac-specific, rises earlier, and is what current guidelines use to diagnose myocardial infarction. The 2026 Fifth Universal Definition of Myocardial Infarction notes that CK-MB may no longer be widely available and treats it as a less sensitive and less specific alternative.
If your report gives a CK-MB activity in U/L, this page converts it to microkatals per litre and back, and nothing more. It cannot tell you whether the value is cardiac. It cannot be put into the CK-MB relative index, whose published cut-offs are defined for the mass assay. And a normal activity result does not exclude myocardial injury, because that is not what this assay is sensitive enough to do. The quoted interval on this page is indicative rather than authoritative: activity-based CK-MB methods have never been harmonised between manufacturers, so the number that matters is the one printed beside the result on your own report.
Frequently asked questions
How do I convert CK-MB from U/L to µkat/L?
Divide by 60. One unit is one micromole of substrate converted per minute and one katal is one mole per second, so 1 U/L = 0.0166667 µkat/L = 16.6667 nkat/L. U/L and IU/L are the same number. Nothing about CK-MB itself affects the conversion.
Is CK-MB activity the same as CK-MB mass?
No. Activity assays report how fast the enzyme works, in U/L; mass assays report how much CK-MB protein is present, in ng/mL or µg/L. They are different measurements on unrelated scales, no factor converts between them, and a threshold quoted for one must never be applied to the other.
Why did laboratories stop using CK-MB activity assays?
Because the immunoinhibition method has poor analytical sensitivity and is falsely raised by adenylate kinase released from red cells in a haemolysed sample and by macro-CK, a benign immunoglobulin-bound complex. Mass assays replaced it, and high-sensitivity troponin has since largely replaced CK-MB altogether.
Why is there no nmol/L conversion for CK-MB activity?
Because an activity is not a concentration of protein. U/L describes what the enzyme does per unit time; there is no molecular weight to divide by, so no molar equivalent exists. Only the mass assay measures an amount of CK-MB, and even that is reported against an assay calibrator rather than a molar standard.
Can I use a CK-MB activity result in the CK-MB relative index?
No. The published index cut-offs of 3 and 5 are defined for CK-MB mass in ng/mL divided by total CK activity in U/L. Substituting an activity result gives a number on a different scale, and the cut-offs do not transfer to it.
Related calculators
References
- StatPearls. Creatine Kinase MB: Diagnostic Utility and Limitations. StatPearls Publishing; NCBI Bookshelf NBK557591.
- Joint ESC/ACC/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Fifth Universal Definition of Myocardial Infarction (2026). Circulation. 2026. doi:10.1161/CIR.0000000000001477.
- Dybkaer R. Unit "katal" for catalytic activity (IUPAC Technical Report). Pure Appl Chem. 2001;73(6):927–931.
- DiaSys Diagnostic Systems. CK-MB reference ranges. Holzheim, Germany; accessed 2026.
Medical Disclaimer: The tools and content provided here are for educational and reference purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Clinical decisions should always be based on the comprehensive assessment of a qualified healthcare professional.